| Induced pluripotent stem cell lines derived from human somatic cells J Yu, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, ... science 318 (5858), 1917-1920, 2007 | 13251 | 2007 |
| Integrative analysis of 111 reference human epigenomes A Kundaje, W Meuleman, J Ernst, M Bilenky, A Yen, A Heravi-Moussavi, ... Nature 518 (7539), 317-330, 2015 | 5962 | 2015 |
| Human induced pluripotent stem cells free of vector and transgene sequences J Yu, K Hu, K Smuga-Otto, S Tian, R Stewart, II Slukvin, JA Thomson Science 324 (5928), 797-801, 2009 | 2980 | 2009 |
| Human embryonic stem cell–derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential MA Vodyanik, JA Bork, JA Thomson, II Slukvin Blood 105 (2), 617-626, 2005 | 784 | 2005 |
| Epigenomic analysis of multilineage differentiation of human embryonic stem cells W Xie, MD Schultz, R Lister, Z Hou, N Rajagopal, P Ray, JW Whitaker, ... Cell 153 (5), 1134-1148, 2013 | 771 | 2013 |
| Hematopoietic and endothelial differentiation of human induced pluripotent stem cells KD Choi, J Yu, K Smuga-Otto, G Salvagiotto, W Rehrauer, M Vodyanik, ... Stem cells 27 (3), 559-567, 2009 | 615 | 2009 |
| Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures MA Vodyanik, JA Thomson, II Slukvin Blood 108 (6), 2095-2105, 2006 | 423 | 2006 |
| A mesoderm-derived precursor for mesenchymal stem and endothelial cells MA Vodyanik, J Yu, X Zhang, S Tian, R Stewart, JA Thomson, II Slukvin Cell stem cell 7 (6), 718-729, 2010 | 373 | 2010 |
| Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells K Hu, J Yu, K Suknuntha, S Tian, K Montgomery, KD Choi, R Stewart, ... Blood, The Journal of the American Society of Hematology 117 (14), e109-e119, 2011 | 304 | 2011 |
| Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell–derived lin–CD34+CD43+CD45+ progenitors KD Choi, MA Vodyanik, II Slukvin The Journal of clinical investigation 119 (9), 2818-2829, 2009 | 263 | 2009 |
| Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures KD Choi, MA Vodyanik, PP Togarrati, K Suknuntha, A Kumar, F Samarjeet, ... Cell reports 2 (3), 553-567, 2012 | 245 | 2012 |
| Nonirradiated NOD, B6. SCID Il2rγ−/− KitW41/W41 (NBSGW) mice support multilineage engraftment of human hematopoietic cells BE McIntosh, ME Brown, BM Duffin, JP Maufort, DT Vereide, II Slukvin, ... Stem cell reports 4 (2), 171-180, 2015 | 213 | 2015 |
| Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose … AJC Bloor, A Patel, JE Griffin, MH Gilleece, R Radia, DT Yeung, D Drier, ... Nature medicine 26 (11), 1720-1725, 2020 | 207 | 2020 |
| Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts A Kumar, SS D’Souza, OV Moskvin, H Toh, B Wang, J Zhang, S Swanson, ... Cell reports 19 (9), 1902-1916, 2017 | 205 | 2017 |
| Generation of red blood cells from human induced pluripotent stem cells J Dias, M Gumenyuk, HJ Kang, M Vodyanik, J Yu, JA Thomson, II Slukvin Stem cells and development 20 (9), 1639-1647, 2011 | 205 | 2011 |
| Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators I Elcheva, V Brok-Volchanskaya, A Kumar, P Liu, JH Lee, L Tong, ... Nature communications 5 (1), 4372, 2014 | 202 | 2014 |
| Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells KD Choi, M Vodyanik, II Slukvin Nature protocols 6 (3), 296-313, 2011 | 199 | 2011 |
| Human embryonic stem cells reprogram myeloid precursors following cell–cell fusion J Yu, MA Vodyanik, P He, II Slukvin, JA Thomson Stem cells 24 (1), 168-176, 2006 | 198 | 2006 |
| Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway II Slukvin, MA Vodyanik, JA Thomson, ME Gumenyuk, KD Choi The Journal of Immunology 176 (5), 2924-2932, 2006 | 170 | 2006 |
| CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus HJ Kang, P Minder, MA Park, WT Mesquitta, BE Torbett, II Slukvin Molecular Therapy-Nucleic Acids 4, 2015 | 162 | 2015 |
